Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation

Radiation Oncology

Volumn 6, Issue 1, 2011, Pages

  Niewald, Marcus ^a   Berdel, Christian ^a   Fleckenstein, Jochen ^a   Licht, Norbert ^a   Ketter, Ralf ^a   Rübe, Christian ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Bone marrow; Chemotherapy; Glioblastoma; Radiotherapy; Toxicity

Indexed keywords

LIVER ENZYME; TEMOZOLOMIDE; ALKYLATING AGENT; DACARBAZINE; DRUG DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BLOOD TOXICITY; BONE MARROW; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG WITHDRAWAL; FATALITY; FEMALE; GLIOBLASTOMA; HEALTH STATUS; HEPATITIS; HISTOPATHOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LEUKOPENIA; MALE; MEDICAL LITERATURE; MEDICAL RECORD; PNEUMONIA; PROBABILITY; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; SURVIVAL TIME; THROMBOCYTOPENIA; BRAIN TUMOR; METHODOLOGY; MIDDLE AGED; RISK; TIME; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CHEMORADIOTHERAPY; DACARBAZINE; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK; TIME FACTORS; TREATMENT OUTCOME;

EID: 80054763805     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-6-141     Document Type: Article

References (27)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England journal of medicine 2005, 352:987-996. 10.1056/NEJMoa043330, 15758009.
2. Jalali R, Singh P, Menon H, Gujral S. Unexpected case of aplastic anemia in a patient with glioblastoma multiforme treated with Temozolomide. J Neurooncol 2007, 85:105-107. 10.1007/s11060-007-9398-z, 17505778.
3. Nagane M, Nozue K, Shimizu S, Waha A, Miyazaki H, Kurita H, Homori M, Fujioka Y, Shiokawa Y. Prolonged and severe thrombocytopenia with pancytopenia induced by radiation-combined temozolomide therapy in a patient with newly diagnosed glioblastoma--analysis of O6-methylguanine-DNA methyltransferase status. J Neurooncol 2009, 92:227-232. 10.1007/s11060-008-9754-7, 19037596.
4. Singhal N, Selva-Nayagam S, Brown MP. Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment-case study and review of literature. J Neurooncol 2007, 85:229-230. 10.1007/s11060-007-9403-6, 17530175.
5. Chheda MG, Drappatz J, Greenberger NJ, Kesari S, Weiss SE, Gigas DC, Doherty LM, Wen PY. Hepatitis B reactivation during glioblastoma treatment with temozolomide: a cautionary note. Neurology 2007, 68:955-956. 10.1212/01.wnl.0000259430.48835.b5, 17372135.
6. Common Toxicity Criteria. 2006, http://www.eortc.be/services/doc/ctc/ctcaev3.pdf
7. Newlands ES, O'Reilly SM, Glaser MG, Bower M, Evans H, Brock C, Brampton MH, Colquhoun I, Lewis P, Rice-Edwards JM, et al. The Charing Cross Hospital experience with temozolomide in patients with gliomas. Eur J Cancer 1996, 32A:2236-2241.
8. O'Reilly SM, Newlands ES, Glaser MG, Brampton M, Rice-Edwards JM, Illingworth RD, Richards PG, Kennard C, Colquhoun IR, Lewis P, et al. Temozolomide: a new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours. Eur J Cancer 1993, 29A:940-942.
9. Brock CS, Newlands ES, Wedge SR, Bower M, Evans H, Colquhoun I, Roddie M, Glaser M, Brampton MH, Rustin GJ. Phase I trial of temozolomide using an extended continuous oral schedule. Cancer Res 1998, 58:4363-4367.
10. Stupp R, Dietrich PY, Ostermann Kraljevic S, Pica A, Maillard I, Maeder P, Meuli R, Janzer R, Pizzolato G, Miralbell R, et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2002, 20:1375-1382.
11. Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D, Antonadou D, Saris G, Beroukas K, Karageorgis P. Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2005, 23:2372-2377.
12. Armstrong TS, Cao Y, Vera E, et al. Pharmacoepidemiology of myelotoxicity (TOX) with temozolomide 8TEM) in malignant glioma patients. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 2008, 26(15S):S513.
13. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlentherapie Und Onkologie: Organ Der Deutschen Röntgengesellschaft [Et Al] 2005, 181:372-377.
14. Combs SE, Wagner J, Bischof M, Welzel T, Edler L, Rausch R, Wagner F, Zabel-du Bois A, Debus J, Schulz-Ertner D. Radiochemotherapy in patients with primary glioblastoma comparing two temozolomide dose regimens. Int J Radiat Oncol Biol Phys 2008, 71:999-1005. 10.1016/j.ijrobp.2007.11.064, 18258384.
15. Fiorica F, Berretta M, Colosimo C, Stefanelli A, Ursino S, Zanet E, Palmucci T, Maugeri D, Malaguarnera M, Palmucci S, et al. Glioblastoma in elderly patients: safety and efficacy of adjuvant radiotherapy with concomitant temozolomide. Arch Gerontol Geriatr 51:31-35.
16. Gerber DE, Grossman SA, Zeltzman M, Parisi MA, Kleinberg L. The impact of thrombocytopenia from temozolomide and radiation in newly diagnosed adults with high-grade gliomas. Neuro Oncol 2007, 9:47-52. 1828105, 17108062.
17. Gerstein J, Franz K, Steinbach JP, Seifert V, Fraunholz I, Weiss C, Rödel C. Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiotherapy And Oncology: Journal Of The European Society For Therapeutic Radiology And Oncology 97:382-386.
18. Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim do H, Kim WS, Nam DH. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Clin Neurol Neurosurg 2009, 111:679-682. 10.1016/j.clineuro.2009.06.013, 19640635.
19. Kimple RJ, Grabowski S, Papez M, Collichio F, Ewend MG, Morris DE. Concurrent temozolomide and radiation, a reasonable option for elderly patients with glioblastoma multiforme?. Am J Clin Oncol 33:265-270.
20. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G, Tombolini V, Maurizi Enrici R. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 2008, 88:97-103. 10.1007/s11060-008-9538-0, 18250965.
21. Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C. Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials. Cancer Treat Rev 1997, 23:35-61. 10.1016/S0305-7372(97)90019-0, 9189180.
22. Grewal J, Dellinger CA, Yung WK. Fatal reactivation of hepatitis B with temozolomide. N Engl J Med 2007, 356:1591-1592. 10.1056/NEJMc063696, 17429098.
23. Neyns B, Hoorens A, Stupp R. Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide. Acta Neurol Belg 2008, 108:131-134.
24. Chamberlain MC. Temozolomide: therapeutic limitations in the treatment of adult high-grade gliomas. Expert Rev Neurother 10:1537-1544.
25. Armstrong TS, Cao Y, Scheurer ME, Vera-Bolanos E, Manning R, Okcu MF, Bondy M, Zhou R, Gilbert MR. Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors. Neuro Oncol 2009, 11:825-832. 10.1215/15228517-2008-120, 2802402, 19179423.
26. Combs SE, Gutwein S, Schulz-Ertner D, van Kampen M, Thilmann C, Edler L, Wannenmacher MM, Debus J. Temozolomide combined with irradiation as postoperative treatment of primary glioblastoma multiforme. Phase I/II study. Strahlentherapie und Onkologie 2005, 181:372-377. 10.1007/s00066-005-1359-x, 15925979.
27. Jeon HJ, Kong DS, Park KB, Lee JI, Park K, Kim JH, Kim ST, Lim DH, Kim WS, Nam D-H. Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience. Clinical Neurology And Neurosurgery 2009, 111:679-682. 10.1016/j.clineuro.2009.06.013, 19640635.